Abstract

In <i>The</i> News: A roundup of news and information from our community

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
NIH's New NCATS: Bridging the Gulf From Bench to Bedside
William B Millard
Annals of Emergency Medicine | VOL. 58
William B MillardWilliam B Millard
21 Jul 2011
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Kenneth C Anderson ... Riccardo Dalla-Favera
Cancer Epidemiology Biomarkers &amp; Prevention | VOL. 31
Kenneth C Anderson, et. al.Kenneth C Anderson ... Riccardo Dalla-Favera
02 Nov 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Kenneth C Anderson ... Elaine R Mardis
Cancer Discovery | VOL. 12
Kenneth C Anderson, et. al.Kenneth C Anderson ... Elaine R Mardis
02 Nov 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
Kenneth C Anderson ... Elizabeth A Platz
Blood Cancer Discovery | VOL. 3
Kenneth C Anderson, et. al.Kenneth C Anderson ... Elizabeth A Platz
02 Nov 2022
View more papers

More From: Clinical and Translational Science

Paper Title
Journal
Date
Author
A phase I randomized study to evaluate safety, pharmacokinetics, and pharmacodynamics of SIR2446M, a selective RIPK1 inhibitor, in healthy participants.
Ana Liza Andresan Sun ... Linan Song
Clinical and Translational Science | VOL. 17
Ana Liza Andresan Sun, et. al.Ana Liza Andresan Sun ... Linan Song
01 Jul 2024
A phase I thorough QT/QTc study evaluating therapeutic and supratherapeutic doses of avacopan in healthy participants.
Shichang Miao ... Rajneet K Oberoi
Clinical and Translational Science | VOL. 17
Shichang Miao, et. al.Shichang Miao ... Rajneet K Oberoi
01 Jul 2024
Dalzanemdor (SAGE-718), a novel, investigational N-methyl-D-aspartate receptor positive allosteric modulator: Safety, tolerability, and clinical pharmacology in randomized dose-finding studies in healthy participants and an open-label study in participants with Huntington's disease.
Aaron Koenig ... Mike Quirk
Clinical and Translational Science | VOL. 17
Aaron Koenig, et. al.Aaron Koenig ... Mike Quirk
01 Jul 2024
Protective effect of clusterin against interleukin-1β-induced apoptosis and inflammation in human knee osteoarthritis chondrocytes.
Tachatra Ungsudechachai ... Wanvisa Udomsinprasert
Clinical and Translational Science | VOL. 17
Tachatra Ungsudechachai, et. al.Tachatra Ungsudechachai ... Wanvisa Udomsinprasert
01 Jul 2024
View more papers